The Valley Desk

NCT04745832 · Interventional trial

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Overall registry status Terminated

Phase 3

Conditions Follicular Lymphoma (FL), Marginal Zone Lymphoma, Non Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov